Services

State-of-the-art R&D support from conceptualization, research to product development
Combining biotechnology / bioprocess technology and organic synthesis expertise under one roof, ACIES BIO offers a comprehensive service and R&D support, covering all key development steps for efficient production of biosynthetic natural products, their semi-synthetic derivatives, as well as synthetic compounds. With decades of experience in natural products biosynthesis, biotransformation, synthetic biology approaches as well as synthetic chemistry and with state-of-the-art research facilities, ACIES BIO is capable of taking on and successfully completing even the most challenging projects.
Our R&D support ranges from development of entire production technologies to focused optimization / improvement of a particular step(s) of the process. ACIES BIO integrates all approaches of modern microbial biotechnology and synthetic chemistry, analytical and downstream process (DSP) development, as well as process scale-up to semi-industrial and industrial-scale manufacturing ensuring shorter timelines and optimum results at all stages of your development process. Our integrated approaches, technical expertise and successful track record with international clients, as well as highly competitive pricing, present a clear advantage of choosing ACIES BIO as your preferred partner in R&D outsourcing.

More about our most commonly sought R&D services can be found in the following sections:

We have an open post for Industrial Biotechnology Researcher. If you are eager to innovate and passionate about science, hold PhD with project management skills, have experience in experimental work in microbiology, molecular biology or bioprocess engineering, apply now!

More >>
Scientists at ACIES BIO made a breakthrough innovation: high-value technology that uses unique and economic bioprocess to convert acid waste whey from dairy factories into high value animal feed products (vitamin B12) and clean water in the same process. Check out Whey2Value!



More >>
European Medicines Agency (EMA) granted orphan medicinal product designation to its lead compound CAB1803 for Pantothenate-kinase-associated neurodegeneration (PKAN)

More >>
Within H2020 SME Innovation Associate project we invite a “Disease Model Development Manager” to join our team.




More >>
Acies Bio received the “Jesenko Award” from Biotechnical Faculty of University of Ljubljana. The award recognizes institutions for their outstanding research work in the field of biotechnology.